Deane Retirement Strategies, Inc. Biogen Inc. Transaction History

Deane Retirement Strategies, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 10, 2019	SELL	$278.5 - $352.75 $1.27 Million - $1.61 Million	-4,575 Closed	0 $0
Q3 2018 Oct 03, 2018	SELL	$293.51 - $383.83 $1,761 - $2,302	-6 Reduced 0.13%	4,575 $1.62 Million
Q2 2018 Aug 01, 2018	BUY	$257.52 - $306.91 $17,768 - $21,176	69 Added 1.53%	4,581 $1.33 Million
Q1 2018 Apr 11, 2018	BUY	$260.13 - $367.91 $18,209 - $25,753	70 Added 1.58%	4,512 $1.24 Million
Q4 2017 Jan 10, 2018	SELL	$307.64 - $344.58 $36,609 - $41,005	-119 Reduced 2.61%	4,442 $1.42 Million
Q3 2017 Oct 19, 2017	BUY	$281.15 - $329.69 $1.28 Million - $1.5 Million	4,561	4,561 $1.43 Million

995

131M

1.12M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Deane Retirement Strategies, Inc., based on Form 13F filings with the SEC.

Stay updated on Deane Retirement Strategies, Inc. with notifications on news.